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I-1
MECHANISMS OF NOCICEPTION IN OA
H-G. Schaible. Univ. Hosp. Jena, Jena, Germany
It is not precisely known at which stage of OA pain occurs for the ﬁrst
time. However, once OA is painful, the nociceptive nervous system shows
considerable changes. The correlation between X-ray signs of OA and
severity of pain is often poor, but more recent research in humans points
to a signiﬁcant role of other tissues such as the synovium and/or the
bone marrow in the generation of pain. While some reviews even report
the occurrence of manifest inﬂammation in painful states of OA most
reports agree at least on the involvement of inﬂammatory mediators
such as cytokines in OA. This is signiﬁcant for pain because evidence
accumulates that cytokines have the potential to induce long-lasting
effects on nociceptive nerve ﬁbres by acting directly on neuronal cytokine
receptors. These changes include rapidly developing effects on the
excitability of neurons and more tonic effects on the neuronal expression
of ion channels and receptors involved in nociception. Functionally, in
OA the nociceptive system exhibits a pronounced sensitization towards
mechanical stimuli which can be observed at all levels of the neuraxis.
This was observed in experimental OA models and also in studies in
humans. In addition some experimental OA models provided evidence
for neuropathic changes but the relative contribution of the neuropathic
component is not known. The neuronal changes also include pathological
deﬁcits in the neuronal control of nociception because some forms of
descending inhibition such as the diffuse noxious inhibitory control are
out of order during painful OA.
I-2
FRONTIERS IN IMAGING OA JOINTS
M-A. D’Agostino. Versailles-Saint Quentin en Yvelines Univ., Ambroise Pare´
Hosp., Rheumatology Dept., Boulogne-Billancourt, France
Imaging plays an important role in the management of osteoarthritis (OA)
in daily practice and in the effort to understand the pathogenesis of the
disease as well as in the research for the disease-modifying OA drugs.
The actual difﬁculty is to choose the appropriate imaging technique.
Magnetic resonance imaging (MRI) and ultrasound are the two key
modalities for OA research. MRI offers semiquantitative, quantitative
and compositional assessment. Radiography still has a role in clinical
practice and in clinical trials. However its limitations are now well
known. Ultrasound seems to be useful for both clinical and research
practice. Its unique advantages include the ability to visualize multiple
individual tissue pathologies related to pain (inﬂammation and structural
damage) and several joints at the same time. The use of ultrasound
seems also able to predict clinical outcome. However its real role in the
OA management still needs to be demonstrated.
An overview of the advances and priorities in imaging OA will be
presented.
I-3
BIOMECHANICS (CLINICAL PERSPECTIVES)
T.P. Andriacchi. Stanford Univ., Stanford, CA, USA
Osteoarthritis has been studied on many fronts where the biology, image
based joint structure and functional mechanics measures are most often
studied independently. While speciﬁc factors associated with the disease
process have been identiﬁed, little is known about the interaction of the
diverse factors that inﬂuence the natural progression of the disease.
This presentation introduces an in vivo systems approach to address the
complexity of osteoarthritis using a stimulus-response model that tests
for the functional, biological, structural and clinical response to stimuli
in the form of load, pain or activity modiﬁcation (Figure 1.). The systems
model is illustrated with three studies of patients with knee OA:
• The ﬁrst study applied a load modifying intervention to introduce a
stimulus in the form of a reduced knee adduction moment in patients
with medial knee OA. In this double blind placebo controlled study
patients with the load modiﬁcation had a signiﬁcant reduction in the
adduction moment relative to control as well as a reduction in pain.
The systems approach also provided an analysis into the changes in
overall body function that resulted from the load modiﬁcation and
gave a unique insight into the subtle movement adjustment to the
upper body that can have a profound inﬂuence on reducing load at
the knee.
• The second study used pain modiﬁcation in patients with medial knee
OA as a stimulus using NSAID and analgesic to modify pain relative to
a washout arm of the study. The systems analysis identiﬁed that the
total resultant moment (vector magnitude of the knee moment) was
the most sensitive functional marker to changes in pain. This study
suggests that biomarkers to evaluate treatment effect for OA should
be broadened to include functional biomechanical measures.
• The third study applied an activity modiﬁcation stimulus in the form
of a thirty minute walking event to evaluate the response of serum
levels of COMP relative to baseline (no activity) immediately following
the 30 minute walk and at 30 minute intervals for 6 hours following
the baseline measurement. Three groups were studied: young healthy,
old healthy (no OA) and patients with medial knee OA. COMP levels
were increased immediately after the thirty minute walk and again at
6 hours after the baseline measurements for healthy subjects whereas
older subjects and subjects with knee OA did not have an increase
in COMP at the 6 hour time point. The results suggest the possibility
that the metabolic response in cartilage to an activity stimulus in
older asymptomatic patients is similar to patients with knee OA and
perhapshelps to suggest using an activity stimulus to evaluate the early
development of OA in “at risk” populations.
Figure 1. The elements of the systems model used to introduce stimuli to
an OA system to evaluate the biological structural and clinical response.
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